Skip to main content
Top
Published in: Neurotherapeutics 1/2018

01-01-2018 | Review

Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis

Authors: Paolo Riccio, Rocco Rossano

Published in: Neurotherapeutics | Issue 1/2018

Login to get access

Abstract

Central to the understanding of the relationships between diet, gut microbiota, and vitamins D and A in multiple sclerosis is low-grade inflammation, which is involved in all chronic inflammatory diseases and is influenced by each of the above effectors. We show that food components have either proinflammatory or anti-inflammatory effects and influence both the human metabolism (the “metabolome”) and the composition of gut microbiota. Hypercaloric, high-animal-fat Western diets favor anabolism and change gut microbiota composition towards dysbiosis. Subsequent intestinal inflammation leads to leakage of the gut barrier, disruption of the blood–brain barrier, and neuroinflammation. Conversely, a vegetarian diet, rich in fiber, is coherent with gut eubiosis and a healthy condition. Vitamin D levels, mainly insufficient in a persistent low-grade inflammatory status, can be restored to optimal values only by administration of high amounts of cholecalciferol. At its optimal values (>30 ng/ml), vitamin D requires vitamin A for the binding to the vitamin D receptor and exert its anti-inflammatory action. Both vitamins must be supplied to the subjects lacking vitamin D. We conclude that nutrients, including the nondigestible dietary fibers, have a leading role in tackling the low-grade inflammation associated with chronic inflammatory diseases. Their action is mediated by gut microbiota and any microbial change induced by diet modifies host–microbe interactions in a consequent way, to improve the disease or worsen it.
Appendix
Available only for authorised users
Literature
2.
go back to reference Yong HY, Yong VW. Stop inflammation and you stop neurodegeneration in MS – YES. Mult Scler 2017; 23:1320-1321.CrossRefPubMed Yong HY, Yong VW. Stop inflammation and you stop neurodegeneration in MS – YES. Mult Scler 2017; 23:1320-1321.CrossRefPubMed
3.
go back to reference Amato MP, Derfuss T, Hemmer B, et al. 2016 ECTRIMS Focused Workshop Group. Environmental modifiable risk factors for multiple sclerosis: report from the 2016 ECTRIMS focused workshop. Mult Scler 2017; 6:1352458516686847. Amato MP, Derfuss T, Hemmer B, et al. 2016 ECTRIMS Focused Workshop Group. Environmental modifiable risk factors for multiple sclerosis: report from the 2016 ECTRIMS focused workshop. Mult Scler 2017; 6:1352458516686847.
4.
go back to reference Munger KL, Fitzgerald KC, Freedman MS, et al. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology 2015;85:1694-1701.PubMedCentralCrossRefPubMed Munger KL, Fitzgerald KC, Freedman MS, et al. No association of multiple sclerosis activity and progression with EBV or tobacco use in BENEFIT. Neurology 2015;85:1694-1701.PubMedCentralCrossRefPubMed
5.
go back to reference Napier MD, Poole C, Satten GA, Ashley-Koch A, Marrie RA, Williamson DM. Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions. Arch Environ Occup Health 2016; 71:26-34.CrossRefPubMed Napier MD, Poole C, Satten GA, Ashley-Koch A, Marrie RA, Williamson DM. Heavy metals, organic solvents, and multiple sclerosis: An exploratory look at gene-environment interactions. Arch Environ Occup Health 2016; 71:26-34.CrossRefPubMed
6.
7.
go back to reference Liu Z, Zhang TT, Yu J, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: a meta-analysis. Neuroepidemiology 2016; 47:103-108.CrossRefPubMed Liu Z, Zhang TT, Yu J, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: a meta-analysis. Neuroepidemiology 2016; 47:103-108.CrossRefPubMed
8.
9.
go back to reference Pierrot-Deseilligny C, Souberbielle JC. Vitamin D and multiple sclerosis: an update. Mult Scler Relat Disord 2017; 14:35-45.CrossRefPubMed Pierrot-Deseilligny C, Souberbielle JC. Vitamin D and multiple sclerosis: an update. Mult Scler Relat Disord 2017; 14:35-45.CrossRefPubMed
10.
go back to reference Riccio P, Rossano R, Liuzzi GM. May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimm Dis 2011; 2010:249842. Riccio P, Rossano R, Liuzzi GM. May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. Autoimm Dis 2011; 2010:249842.
11.
go back to reference Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complement Ther Med 2011; 19:228-237.CrossRefPubMed Riccio P. The molecular basis of nutritional intervention in multiple sclerosis: a narrative review. Complement Ther Med 2011; 19:228-237.CrossRefPubMed
12.
go back to reference Riccio P, Rossano R. The role of nutrition in multiple sclerosis: a story yet to be written. Rev Esp Esclerosis Multiple 2013; 5:24-37. Riccio P, Rossano R. The role of nutrition in multiple sclerosis: a story yet to be written. Rev Esp Esclerosis Multiple 2013; 5:24-37.
14.
go back to reference Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18:153-165.CrossRefPubMed Holick MF. The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 2017; 18:153-165.CrossRefPubMed
15.
go back to reference Herieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res 2014; 58:136-146.CrossRefPubMed Herieka M, Erridge C. High-fat meal induced postprandial inflammation. Mol Nutr Food Res 2014; 58:136-146.CrossRefPubMed
16.
go back to reference Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012; 18:1334-1336.CrossRefPubMed Hedström AK, Olsson T, Alfredsson L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult Scler 2012; 18:1334-1336.CrossRefPubMed
17.
go back to reference Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38:1-12.CrossRefPubMed Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain Behav Immun 2014; 38:1-12.CrossRefPubMed
19.
go back to reference Fleck AK, Schuppan D, Wiendl H, Klotz L. Gut-CNS-axis as possibility to modulate inflammatory disease activity-implications for multiple sclerosis. Int J Mol Sci 2017; 18: E1526.CrossRefPubMed Fleck AK, Schuppan D, Wiendl H, Klotz L. Gut-CNS-axis as possibility to modulate inflammatory disease activity-implications for multiple sclerosis. Int J Mol Sci 2017; 18: E1526.CrossRefPubMed
20.
go back to reference Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016; 165:1332-1345.CrossRefPubMed Koh A, De Vadder F, Kovatcheva-Datchary P, Bäckhed F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 2016; 165:1332-1345.CrossRefPubMed
21.
go back to reference Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 13:1476-1483.CrossRef Tilg H, Moschen AR, Kaser A. Obesity and the microbiota. Gastroenterology 2009; 13:1476-1483.CrossRef
22.
go back to reference De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107:14691-14696.PubMedCentralCrossRefPubMed De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107:14691-14696.PubMedCentralCrossRefPubMed
24.
go back to reference Bäckhed F, Fraser CM, Ringel Y, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012; 12:611-622.CrossRefPubMed Bäckhed F, Fraser CM, Ringel Y, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe 2012; 12:611-622.CrossRefPubMed
25.
go back to reference David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559-563.CrossRefPubMed David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505:559-563.CrossRefPubMed
26.
go back to reference Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-546.CrossRefPubMed Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-546.CrossRefPubMed
28.
go back to reference Pols TWH, Puchner T, Korkmaz HI, Vos M, Soeters MR, de Vries CJM. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. PLOS ONE 2017; 12:e0176715.PubMedCentralCrossRefPubMed Pols TWH, Puchner T, Korkmaz HI, Vos M, Soeters MR, de Vries CJM. Lithocholic acid controls adaptive immune responses by inhibition of Th1 activation through the Vitamin D receptor. PLOS ONE 2017; 12:e0176715.PubMedCentralCrossRefPubMed
31.
go back to reference Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017; 19:29-41.CrossRefPubMed Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota. Environ Microbiol 2017; 19:29-41.CrossRefPubMed
32.
go back to reference Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. Front Microbiol 2016; 7:979.PubMedCentralCrossRefPubMed Rivière A, Selak M, Lantin D, Leroy F, De Vuyst L. Bifidobacteria and butyrate-producing colon bacteria: Importance and strategies for their stimulation in the human gut. Front Microbiol 2016; 7:979.PubMedCentralCrossRefPubMed
33.
go back to reference Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 2014; 40:833-842.CrossRefPubMed Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and "western-lifestyle" inflammatory diseases. Immunity 2014; 40:833-842.CrossRefPubMed
34.
go back to reference Telesford KM, Yan W, Ochoa-Reparaz J, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 2015; 6:234-242.PubMedCentralCrossRefPubMed Telesford KM, Yan W, Ochoa-Reparaz J, et al. A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes 2015; 6:234-242.PubMedCentralCrossRefPubMed
35.
go back to reference Quévrain E, Maubert MA, Michon C, et al. Identification of an anti-inflammatory protein from Faecali bacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 2016; 65:415-425.CrossRefPubMed Quévrain E, Maubert MA, Michon C, et al. Identification of an anti-inflammatory protein from Faecali bacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 2016; 65:415-425.CrossRefPubMed
37.
go back to reference Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22:586-597.PubMedCentralCrossRefPubMed Rothhammer V, Mascanfroni ID, Bunse L, et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22:586-597.PubMedCentralCrossRefPubMed
38.
go back to reference Lutgendorff F, Akkermans LM, Söderholm JD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med 2008; 8:282-298.CrossRefPubMed Lutgendorff F, Akkermans LM, Söderholm JD. The role of microbiota and probiotics in stress-induced gastro-intestinal damage. Curr Mol Med 2008; 8:282-298.CrossRefPubMed
39.
go back to reference Shen T, Chen X, Li Y, et al. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochim Biophys Acta 2017; 1863:1510-1518. Shen T, Chen X, Li Y, et al. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation. Biochim Biophys Acta 2017; 1863:1510-1518.
40.
go back to reference Park JH, Jeong SY, Choi AJ, Kim SJ. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. Immunol Lett 2015; 165:10-19.CrossRefPubMed Park JH, Jeong SY, Choi AJ, Kim SJ. Lipopolysaccharide directly stimulates Th17 differentiation in vitro modulating phosphorylation of RelB and NF-κB1. Immunol Lett 2015; 165:10-19.CrossRefPubMed
41.
42.
go back to reference Ochoa-Repáraz J, Kasper LH. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep. 2016; 5(1):51-64. Ochoa-Repáraz J, Kasper LH. The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders? Curr Obes Rep. 2016; 5(1):51-64.
43.
go back to reference Scheperjans F. Can microbiota research change our understanding of neurodegenerative diseases? Neurodegener Dis Manag 2016; 6:81-85.CrossRefPubMed Scheperjans F. Can microbiota research change our understanding of neurodegenerative diseases? Neurodegener Dis Manag 2016; 6:81-85.CrossRefPubMed
44.
go back to reference Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479:538-541.CrossRefPubMed Berer K, Mues M, Koutrolos M, et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 2011; 479:538-541.CrossRefPubMed
45.
go back to reference Miyake S, Kim S, Suda W, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV Clusters. PLOS ONE 2015; 10:e0137429.PubMedCentralCrossRefPubMed Miyake S, Kim S, Suda W, et al. Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV Clusters. PLOS ONE 2015; 10:e0137429.PubMedCentralCrossRefPubMed
46.
47.
go back to reference Mirza A, Mao-Draayer Y. The gut microbiome and microbial translocation in multiple sclerosis. Clin Immunol 2017. Mirza A, Mao-Draayer Y. The gut microbiome and microbial translocation in multiple sclerosis. Clin Immunol 2017.
48.
go back to reference Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015; 30:350-358.CrossRefPubMed Scheperjans F, Aho V, Pereira PA, et al. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 2015; 30:350-358.CrossRefPubMed
49.
go back to reference Bu XL, Yao XQ, Jiao SS, et al. A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol 2015; 22:1519-1525.CrossRefPubMed Bu XL, Yao XQ, Jiao SS, et al. A study on the association between infectious burden and Alzheimer's disease. Eur J Neurol 2015; 22:1519-1525.CrossRefPubMed
50.
go back to reference Bu XL, Wang X, Xiang Y, et al. The association between infectious burden and Parkinson's disease: a case-control study. Parkinsonism Relat Disord 2015; 21:877-881.CrossRefPubMed Bu XL, Wang X, Xiang Y, et al. The association between infectious burden and Parkinson's disease: a case-control study. Parkinsonism Relat Disord 2015; 21:877-881.CrossRefPubMed
51.
go back to reference Buscarinu MC, Cerasoli B, Annibali V, et al. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult Scler 2017; 23:442-446.CrossRefPubMed Buscarinu MC, Cerasoli B, Annibali V, et al. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult Scler 2017; 23:442-446.CrossRefPubMed
52.
go back to reference Wekerle H. Brain autoimmunity and intestinal microbiota. 100 Trillion game changers. Trends Immunol 2017; 1379:1-15. Wekerle H. Brain autoimmunity and intestinal microbiota. 100 Trillion game changers. Trends Immunol 2017; 1379:1-15.
53.
go back to reference Swank RL. Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci 1950; 220:421-430.CrossRefPubMed Swank RL. Multiple sclerosis; a correlation of its incidence with dietary fat. Am J Med Sci 1950; 220:421-430.CrossRefPubMed
54.
go back to reference Swank RL, Goodwin JW. Review of MS patient survival on a Swank low saturated fat diet. Nutrition 2003; 19:161-165.CrossRefPubMed Swank RL, Goodwin JW. Review of MS patient survival on a Swank low saturated fat diet. Nutrition 2003; 19:161-165.CrossRefPubMed
55.
go back to reference Rietschel ET, Brade H, Holst O, et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216:39-81.PubMed Rietschel ET, Brade H, Holst O, et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol 1996; 216:39-81.PubMed
56.
go back to reference Hwang DH, Kim JA, Lee JY. Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol 2016; 785:24-35.CrossRefPubMed Hwang DH, Kim JA, Lee JY. Mechanisms for the activation of Toll-like receptor 2/4 by saturated fatty acids and inhibition by docosahexaenoic acid. Eur J Pharmacol 2016; 785:24-35.CrossRefPubMed
58.
go back to reference Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenicTh17 Cells. Nature 2013; 496:518-522.PubMedCentralCrossRefPubMed Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenicTh17 Cells. Nature 2013; 496:518-522.PubMedCentralCrossRefPubMed
59.
go back to reference Riccio P. The proteins of the milk fat globule membrane in the balance. Trends Food Sci Technol 2004; 15:458-461.CrossRef Riccio P. The proteins of the milk fat globule membrane in the balance. Trends Food Sci Technol 2004; 15:458-461.CrossRef
60.
go back to reference Choi IY, Lee P, Adany P, et al. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis. Mult Scler 2017. Choi IY, Lee P, Adany P, et al. In vivo evidence of oxidative stress in brains of patients with progressive multiple sclerosis. Mult Scler 2017.
61.
go back to reference Frischer JM, Stephan Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-1189.PubMedCentralCrossRefPubMed Frischer JM, Stephan Bramow S, Dal-Bianco A, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-1189.PubMedCentralCrossRefPubMed
63.
go back to reference Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008; 47:147-155.CrossRefPubMed Schmitz G, Ecker J. The opposing effects of n-3 and n-6 fatty acids. Prog Lipid Res 2008; 47:147-155.CrossRefPubMed
64.
go back to reference Fragoso YD, Stoney PN, McCaffery PJ. The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs 2014; 28:291-299.CrossRefPubMed Fragoso YD, Stoney PN, McCaffery PJ. The evidence for a beneficial role of vitamin A in multiple sclerosis. CNS Drugs 2014; 28:291-299.CrossRefPubMed
65.
go back to reference Huang JK, Jarjour AA, Oumesmar BN, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011; 14:45-53.CrossRefPubMed Huang JK, Jarjour AA, Oumesmar BN, et al. Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci 2011; 14:45-53.CrossRefPubMed
66.
go back to reference Qing J. Natural forms of vitamin E: metabolism, antioxidant and anti-inflammatory activities and the role in disease prevention and therapy. Free Radic Biol Med 2014; 72: 76-90.CrossRef Qing J. Natural forms of vitamin E: metabolism, antioxidant and anti-inflammatory activities and the role in disease prevention and therapy. Free Radic Biol Med 2014; 72: 76-90.CrossRef
67.
go back to reference Mastronardi FG, Min W, Wang H, et al. Attenuation of experimental autoimmune encephalomyelitis and non immune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J Immunol 2004; 172:6418-6426.CrossRefPubMed Mastronardi FG, Min W, Wang H, et al. Attenuation of experimental autoimmune encephalomyelitis and non immune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J Immunol 2004; 172:6418-6426.CrossRefPubMed
69.
go back to reference Fenni S, Hammou H, Astier J, et al. Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders. Mol Nutr Food Res 2017; 61(9). Fenni S, Hammou H, Astier J, et al. Lycopene and tomato powder supplementation similarly inhibit high-fat diet induced obesity, inflammatory response, and associated metabolic disorders. Mol Nutr Food Res 2017; 61(9).
70.
73.
go back to reference Riccio P, Giovannelli S, Bobba A, et al. Specificity of zinc binding to myelin basic protein. Neurochem Res 1995; 20:1107-1113.CrossRefPubMed Riccio P, Giovannelli S, Bobba A, et al. Specificity of zinc binding to myelin basic protein. Neurochem Res 1995; 20:1107-1113.CrossRefPubMed
74.
go back to reference Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLOS ONE 2010; 5:e13058.PubMedCentralCrossRefPubMed Salinthone S, Yadav V, Schillace RV, Bourdette DN, Carr DW. Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling. PLOS ONE 2010; 5:e13058.PubMedCentralCrossRefPubMed
75.
go back to reference Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC. Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice. J Neuroinflammation 2013; 10:73.PubMedCentralCrossRefPubMed Takechi R, Pallebage-Gamarallage MM, Lam V, Giles C, Mamo JC. Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice. J Neuroinflammation 2013; 10:73.PubMedCentralCrossRefPubMed
76.
go back to reference Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav 2014; 4:108-122.PubMedCentralCrossRefPubMed Bavarsad Shahripour R, Harrigan MR, Alexandrov AV. N-acetylcysteine (NAC) in neurological disorders: mechanisms of action and therapeutic opportunities. Brain Behav 2014; 4:108-122.PubMedCentralCrossRefPubMed
77.
go back to reference Visioli F, De La Lastra CA, Andres-Lacueva C, et al. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr 2011; 51:524-546.CrossRefPubMed Visioli F, De La Lastra CA, Andres-Lacueva C, et al. Polyphenols and human health: a prospectus. Crit Rev Food Sci Nutr 2011; 51:524-546.CrossRefPubMed
78.
go back to reference Gupta C, Prakash D. Phytonutrients as therapeutic agents. J Complement Integr Med 2014; 11:151-169.CrossRefPubMed Gupta C, Prakash D. Phytonutrients as therapeutic agents. J Complement Integr Med 2014; 11:151-169.CrossRefPubMed
79.
go back to reference Vijayakumar TM, Kumar RM, Agrawal A, Dubey GP, Ilango K. Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening. J Food Sci Technol 2015; 52:4537-4543.CrossRefPubMed Vijayakumar TM, Kumar RM, Agrawal A, Dubey GP, Ilango K. Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening. J Food Sci Technol 2015; 52:4537-4543.CrossRefPubMed
80.
go back to reference Liuzzi GM, Latronico T, Branà MT, et al. Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients. Neurochem Res 2011; 36:518-527.CrossRefPubMed Liuzzi GM, Latronico T, Branà MT, et al. Structure-dependent inhibition of gelatinases by dietary antioxidants in rat astrocytes and sera of multiple sclerosis patients. Neurochem Res 2011; 36:518-527.CrossRefPubMed
81.
go back to reference Amara F, Berbenni M, Fragni M, et al. Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation. Oxid Med Cell Longev 2015; 2015:217258.PubMedCentralCrossRefPubMed Amara F, Berbenni M, Fragni M, et al. Neuroprotection by cocktails of dietary antioxidants under conditions of nerve growth factor deprivation. Oxid Med Cell Longev 2015; 2015:217258.PubMedCentralCrossRefPubMed
82.
go back to reference Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 2017. Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S. Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis. Cell Mol Life Sci 2017.
83.
go back to reference Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519:92-96.PubMedCentralCrossRefPubMed Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519:92-96.PubMedCentralCrossRefPubMed
84.
go back to reference Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota—a review. J Physiol Biochem 2017. Roca-Saavedra P, Mendez-Vilabrille V, Miranda JM, et al. Food additives, contaminants and other minor components: effects on human gut microbiota—a review. J Physiol Biochem 2017.
85.
go back to reference Welzl H, D’Adamo P, Lipp HP. Conditioned taste aversion as a learning and memory paradigm. Behav Brain Res 2001; 125:205-213.CrossRefPubMed Welzl H, D’Adamo P, Lipp HP. Conditioned taste aversion as a learning and memory paradigm. Behav Brain Res 2001; 125:205-213.CrossRefPubMed
86.
go back to reference Weiland TJ, Hadgkiss EJ, Jelinek GA, et al. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014; 336:211-219.CrossRefPubMed Weiland TJ, Hadgkiss EJ, Jelinek GA, et al. The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis. J Neurol Sci 2014; 336:211-219.CrossRefPubMed
87.
go back to reference Allais L, Kerckhof FM, Verschuere S, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol 2016; 18:1352-1363.CrossRefPubMed Allais L, Kerckhof FM, Verschuere S, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol 2016; 18:1352-1363.CrossRefPubMed
88.
go back to reference Hedström AK, Hillert J, Olsson T, Alfredsson L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol 2014; 71:300-305.CrossRefPubMed Hedström AK, Hillert J, Olsson T, Alfredsson L. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. JAMA Neurol 2014; 71:300-305.CrossRefPubMed
89.
go back to reference Samuelson DR, Shellito JE, Maffei VJ, et al. Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. PLOS Pathog 2017; 13:e1006426.PubMedCentralCrossRefPubMed Samuelson DR, Shellito JE, Maffei VJ, et al. Alcohol-associated intestinal dysbiosis impairs pulmonary host defense against Klebsiella pneumoniae. PLOS Pathog 2017; 13:e1006426.PubMedCentralCrossRefPubMed
90.
91.
go back to reference Choi IY, Piccio L, Childress P, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep 2016; 15:2136-2146.PubMedCentralCrossRefPubMed Choi IY, Piccio L, Childress P, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell Rep 2016; 15:2136-2146.PubMedCentralCrossRefPubMed
92.
go back to reference Clauw DJ. Guided graded exercise self-help as a treatment of fatigue in chronic fatigue syndrome. Lancet 2017; 390:335-336.CrossRefPubMed Clauw DJ. Guided graded exercise self-help as a treatment of fatigue in chronic fatigue syndrome. Lancet 2017; 390:335-336.CrossRefPubMed
93.
go back to reference Gacias M, Casaccia P. Promoting return of function in multiple sclerosis: an integrated approach. Mult Scler Relat Disord 2013; 2(4). Gacias M, Casaccia P. Promoting return of function in multiple sclerosis: an integrated approach. Mult Scler Relat Disord 2013; 2(4).
94.
go back to reference Mokhtarzade M, Ranjbar R, Majdinasab N, Patel D, Molanouri Shamsi M. Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine 2017; 57:262-271.CrossRefPubMed Mokhtarzade M, Ranjbar R, Majdinasab N, Patel D, Molanouri Shamsi M. Effect of aerobic interval training on serum IL-10, TNFα, and adipokines levels in women with multiple sclerosis: possible relations with fatigue and quality of life. Endocrine 2017; 57:262-271.CrossRefPubMed
95.
go back to reference Lunde LK, Skare Ø, Aass HC, et al. Physical activity initiated by employer induces improvements in a novel set of biomarkers of inflammation: an 8-week follow-up study. Eur J Appl Physiol 2017; 117:521-532.PubMedCentralCrossRefPubMed Lunde LK, Skare Ø, Aass HC, et al. Physical activity initiated by employer induces improvements in a novel set of biomarkers of inflammation: an 8-week follow-up study. Eur J Appl Physiol 2017; 117:521-532.PubMedCentralCrossRefPubMed
96.
go back to reference Petriz BA, Castro AP, Almeida JA, et al. Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats. BMC Genomics. 2014;15:511.PubMedCentralCrossRefPubMed Petriz BA, Castro AP, Almeida JA, et al. Exercise induction of gut microbiota modifications in obese, non-obese and hypertensive rats. BMC Genomics. 2014;15:511.PubMedCentralCrossRefPubMed
97.
98.
go back to reference Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2012; 12:CD004192.PubMed Farinotti M, Vacchi L, Simi S, Di Pietrantonj C, Brait L, Filippini G. Dietary interventions for multiple sclerosis. Cochrane Database Syst Rev 2012; 12:CD004192.PubMed
99.
100.
101.
go back to reference Bisht B, Darling WG, Grossmann RE, et al. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med 2014; 20:347-355.PubMedCentralCrossRefPubMed Bisht B, Darling WG, Grossmann RE, et al. A multimodal intervention for patients with secondary progressive multiple sclerosis: feasibility and effect on fatigue. J Altern Complement Med 2014; 20:347-355.PubMedCentralCrossRefPubMed
103.
104.
105.
go back to reference Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med (Maywood) 2016; 24:620-635.CrossRef Riccio P, Rossano R, Larocca M, et al. Anti-inflammatory nutritional intervention in patients with relapsing-remitting and primary-progressive multiple sclerosis: a pilot study. Exp Biol Med (Maywood) 2016; 24:620-635.CrossRef
106.
go back to reference Rossano R, Larocca M, Riviello L, et al. Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. J Cell Mol Med 2014; 18:242-252.CrossRefPubMed Rossano R, Larocca M, Riviello L, et al. Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. J Cell Mol Med 2014; 18:242-252.CrossRefPubMed
107.
go back to reference Ascherio A, Munger KL. Epidemiology of multiple sclerosis: from risk factors to prevention—an update. Semin Neurol 2016; 36:103-114.CrossRefPubMed Ascherio A, Munger KL. Epidemiology of multiple sclerosis: from risk factors to prevention—an update. Semin Neurol 2016; 36:103-114.CrossRefPubMed
108.
go back to reference Charalambidou E., Pantzaris M., Patrikios I. Multiple sclerosis in Cyprus: a fourteen year (2000–2014) epidemiological study. Am J Epidemiol Infect Dis 2016; 4:1-9. Charalambidou E., Pantzaris M., Patrikios I. Multiple sclerosis in Cyprus: a fourteen year (2000–2014) epidemiological study. Am J Epidemiol Infect Dis 2016; 4:1-9.
109.
go back to reference Massacesi L, Abbamondi AL, Giorgi C, Sarlo F, Lolli F, Amaducci L. Suppression of experimental allergic encephalomyelitis by retinoic acid. J Neurol Sci 1987; 80:55-64.CrossRefPubMed Massacesi L, Abbamondi AL, Giorgi C, Sarlo F, Lolli F, Amaducci L. Suppression of experimental allergic encephalomyelitis by retinoic acid. J Neurol Sci 1987; 80:55-64.CrossRefPubMed
110.
go back to reference Al-Daghri NM, Guerini FR, Al-Attas OS, et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLOS ONE 2014; 9:e102141.PubMedCentralCrossRefPubMed Al-Daghri NM, Guerini FR, Al-Attas OS, et al. Vitamin D receptor gene polymorphisms are associated with obesity and inflammosome activity. PLOS ONE 2014; 9:e102141.PubMedCentralCrossRefPubMed
111.
go back to reference Polidoro L, Properzi G, Marampon F, et al. Vitamin D protects human endothelial cells from H2O2 oxidant injury through the Mek/Erk-Sirt1 axis activation. J Cardiovasc Transl Res 2013; 6:221-231.CrossRefPubMed Polidoro L, Properzi G, Marampon F, et al. Vitamin D protects human endothelial cells from H2O2 oxidant injury through the Mek/Erk-Sirt1 axis activation. J Cardiovasc Transl Res 2013; 6:221-231.CrossRefPubMed
112.
go back to reference Zhao H, Zhang H, Wu H, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 2012; 12:57.PubMedCentralCrossRefPubMed Zhao H, Zhang H, Wu H, et al. Protective role of 1,25(OH)2 vitamin D3 in the mucosal injury and epithelial barrier disruption in DSS-induced acute colitis in mice. BMC Gastroenterol 2012; 12:57.PubMedCentralCrossRefPubMed
113.
go back to reference Jin D, Wu S, Zhang YG, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther 2015; 37:996-1009.CrossRefPubMed Jin D, Wu S, Zhang YG, et al. Lack of vitamin D receptor causes dysbiosis and changes the functions of the murine intestinal microbiome. Clin Ther 2015; 37:996-1009.CrossRefPubMed
114.
go back to reference Sun J. VDR/vitamin D receptor regulates autophagic activity through ATG16L1. Autophagy 2016; 12:1057-1058.CrossRefPubMed Sun J. VDR/vitamin D receptor regulates autophagic activity through ATG16L1. Autophagy 2016; 12:1057-1058.CrossRefPubMed
116.
go back to reference Pantzaris MC, Loukaides GN, Ntzani EE, Patrikios IS. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open 2013; 3:e002170.PubMedCentralCrossRefPubMed Pantzaris MC, Loukaides GN, Ntzani EE, Patrikios IS. A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial. BMJ Open 2013; 3:e002170.PubMedCentralCrossRefPubMed
119.
go back to reference Smith P, Willemsen D, Popkes ML, et al. Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife 2017;6:e27014.PubMedCentralPubMed Smith P, Willemsen D, Popkes ML, et al. Regulation of life span by the gut microbiota in the short-lived African turquoise killifish. Elife 2017;6:e27014.PubMedCentralPubMed
121.
go back to reference Foster KR, Schluter J, Coyte KZ, Rakoff-Nahoum S. The evolution of the host microbiome as an ecosystem on a leash. Nature 2017; 548:43-51.CrossRefPubMed Foster KR, Schluter J, Coyte KZ, Rakoff-Nahoum S. The evolution of the host microbiome as an ecosystem on a leash. Nature 2017; 548:43-51.CrossRefPubMed
122.
go back to reference Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016; 535:56-64.CrossRefPubMed Sonnenburg JL, Bäckhed F. Diet-microbiota interactions as moderators of human metabolism. Nature 2016; 535:56-64.CrossRefPubMed
123.
124.
go back to reference Ochoa-Repáraz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011; 69:240-247.CrossRefPubMed Ochoa-Repáraz J, Mielcarz DW, Begum-Haque S, Kasper LH. Gut, bugs, and brain: role of commensal bacteria in the control of central nervous system disease. Ann Neurol 2011; 69:240-247.CrossRefPubMed
125.
go back to reference Fernández Ó, Álvarez-Cermeño JC, Arroyo-González R, et al. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Rev Neurol 2012; 54:677-691.PubMed Fernández Ó, Álvarez-Cermeño JC, Arroyo-González R, et al. Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Rev Neurol 2012; 54:677-691.PubMed
126.
go back to reference Esposito S, Bonavita S, Sparaco M, Gallo A, Tedeschi G. The role of diet in multiple sclerosis: a review. Nutr Neurosci 2017; 1-14. Esposito S, Bonavita S, Sparaco M, Gallo A, Tedeschi G. The role of diet in multiple sclerosis: a review. Nutr Neurosci 2017; 1-14.
127.
go back to reference Altowaijri G, Fryman A, Yadav V. Dietary interventions and multiple sclerosis. Curr Neurol Neurosci Rep 2017; 17:28.CrossRefPubMed Altowaijri G, Fryman A, Yadav V. Dietary interventions and multiple sclerosis. Curr Neurol Neurosci Rep 2017; 17:28.CrossRefPubMed
128.
go back to reference Bagur MJ, Murcia MA, Jiménez-Monreal AM, et al. Influence of diet in multiple sclerosis: a systematic review. Adv Nutr 2017; 8:463-472.CrossRefPubMed Bagur MJ, Murcia MA, Jiménez-Monreal AM, et al. Influence of diet in multiple sclerosis: a systematic review. Adv Nutr 2017; 8:463-472.CrossRefPubMed
129.
go back to reference Wekerle H. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology (Oxford) 2016; 55:68-75.CrossRef Wekerle H. The gut-brain connection: triggering of brain autoimmune disease by commensal gut bacteria. Rheumatology (Oxford) 2016; 55:68-75.CrossRef
130.
go back to reference Cosorich I, Dalla-Costa G, Sorini C, et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 2017; 3:e1700492.PubMedCentralCrossRefPubMed Cosorich I, Dalla-Costa G, Sorini C, et al. High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis. Sci Adv 2017; 3:e1700492.PubMedCentralCrossRefPubMed
131.
go back to reference Dunn M, Bhargava P, Kalb R. Your patients with multiple sclerosis have set wellness as a high priority—and the national multiple sclerosis society is responding. US Neurology 2015; 11:80-86.CrossRef Dunn M, Bhargava P, Kalb R. Your patients with multiple sclerosis have set wellness as a high priority—and the national multiple sclerosis society is responding. US Neurology 2015; 11:80-86.CrossRef
132.
go back to reference Motl RW, Mowry EM, Ehde DM, et al. Wellness and multiple sclerosis: the national MS society establishes a wellness research working group and research priorities. Mult Scler 2017. Motl RW, Mowry EM, Ehde DM, et al. Wellness and multiple sclerosis: the national MS society establishes a wellness research working group and research priorities. Mult Scler 2017.
Metadata
Title
Diet, Gut Microbiota, and Vitamins D + A in Multiple Sclerosis
Authors
Paolo Riccio
Rocco Rossano
Publication date
01-01-2018
Publisher
Springer US
Published in
Neurotherapeutics / Issue 1/2018
Print ISSN: 1933-7213
Electronic ISSN: 1878-7479
DOI
https://doi.org/10.1007/s13311-017-0581-4

Other articles of this Issue 1/2018

Neurotherapeutics 1/2018 Go to the issue